• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.15% Nasdaq Down 0.11%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    2.89 Up 0.06(2.12%) Apr 21, 4:00PM EDT
    Prev Close:2.83
    Open:2.85
    Bid:2.87 x 1000
    Ask:6.19 x 600
    1y Target Est:10.00
    Beta:2.89704
    Earnings Date:May 2 - May 8 (Est.)
    Day's Range:2.81 - 2.91
    52wk Range:1.65 - 6.50
    Volume:172,257
    Avg Vol (3m):445,911
    Market Cap:44.01M
    P/E (ttm):N/A
    EPS (ttm):-1.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREXUp 2.12%44.01M
    GSKUp 0.17%97.04B
    ABTDown 1.02%75.22B
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :-8.55
    Quarterly EPS Est (Mar-17) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.00

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback